Radiomic biomarkers of tumor immune biology and immunotherapy response

Immunotherapies are leading to improved outcomes for many cancers, including those with devastating prognoses. As therapies like immune checkpoint inhibitors (ICI) become a mainstay in treatment regimens, many concurrent challenges have arisen – for instance, delineating clinical responders from non...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jarey H., Wahid, Kareem A., van Dijk, Lisanne V., Farahani, Keyvan, Thompson, Reid F., Fuller, Clifton David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076712/
https://www.ncbi.nlm.nih.gov/pubmed/33937530
http://dx.doi.org/10.1016/j.ctro.2021.03.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076712/
https://www.ncbi.nlm.nih.gov/pubmed/33937530
http://dx.doi.org/10.1016/j.ctro.2021.03.006

Ejemplares similares